New combo tackles tough neuroendocrine tumors
NCT ID NCT05746208
First seen Mar 24, 2026 · Last updated May 24, 2026 · Updated 8 times
Summary
This study tests a combination of two drugs (lenvatinib and pembrolizumab) in people with a rare, fast-growing type of neuroendocrine tumor called well-differentiated grade 3 (WD G3 NET). About 29 adults with advanced tumors that cannot be removed by surgery will receive the treatment. The main goal is to see how many patients' tumors shrink or disappear. Researchers will also collect blood samples and use special scans to learn how the drugs affect the tumor and its environment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.